Drug Trial Radar · NCT01390961
Comparison of Tolerability Between Two Allergy Drops
Last checked: Nov 19, 2026Latest source record: Jul 11, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
48
Planned (sponsor's estimate)
Start
Aug 2011
Primary completion
Dec 2011
Study completion Jan 2012
Sponsor
- Lead sponsor
- Hom, Milton M., OD, FAAOIndividual
- Sponsor type
- Individual
- Collaborators
- Allergan
- First posted
- Jul 11, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Comfort is compared between two allergy drops
Conditions
- Allergic Conjunctivitis
Interventions
alacaftadine and naphazoline HCl & pheniramine maleateDrug
once a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- TolerabilityTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Milton M. Hom, OD, FAAO.
Azusa, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.